ArticleBMC plant biology2026
Leveraging natural climatic advantages for large‑scale wheat doubled haploid production via wheat × maize: a protocol optimization study.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundDoubled haploid (DH) lines generated via the wheat × maize system represent an effective technology for accelerating wheat breeding. However, achieving low-cost, large-scale DH production remains a core technical challenge.
resultsIn this study, we conducted flowering-synchronization experiments to determine the hybridization window between wheat and maize. Wheat was sown year-round in the field, while maize was planted both in the field and in high tunnels. We also evaluated a novel pollination method, four new nutrition solutions for cut-tiller culture, and a newly designed optical device for screening embryo-containing caryopses prior to embryo rescue. The results are as follows: (i) spring wheat, as well as vernalized facultative and winter wheat can be naturally grown year-round in Kunming, a plateau region in China with a mild climate. The hybridization window between wheat and maize is five months (June-October) in natural conditions, but can be extended to 10 months (April-next January) through high-tunnel maize cultivation in January-February and August-September; (ii) compared with commonly used brushing pollen pollination, the rolling pollination method increased pollination efficiency more than tenfold, and raised the haploid embryo formation frequency (EFF) by 1.9 times; (iii) one new nutrient solution (A) for cut-tiller culture performed significantly better than the currently used nutrient solution B. It achieved the highest EFF (46.39%), caryopsis setting rate (97.20%), and 1000-caryopsis weight (28.49 g) among five solutions. Solution A, without sulfurous acid and silver nitrate (both present in solution B), is also more cost-effective and environmentally friendly; (iv) pre-screening caryopses using a newly designed optical device prior to embryo rescue demonstrated a 98.6% accuracy rate and a 3.46% false-negative rate in selecting embryo-containing caryopses. This method doubles the efficiency of embryo rescue and remarkably reduces the use of sterilants and labor in mass DH production. The optimized protocols were validated from 2022 to 2024, yielding over 137,080 DH lines from 1,039 diverse wheat materials.
conclusionsThe optimized protocol significantly improved doubled haploid production efficiency and reduced its cost, providing a more efficient and cost-effective system for mass production of wheat doubled haploids via wheat × maize. It is expected that the optimized protocol for wheat DH production will be applicable in regions with similar climates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.